Eco Animal Health Group PlcLSE: EAH

Result of AGM

25 September 2025

ECO Animal Health Group plc

("ECO" or the "Company")

Result of Annual General Meeting

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that at its Annual General Meeting held today all resolutions proposed to the meeting were duly passed.

Votes received in relation to each resolution were as follows:

Resolution

For

%

Discretionary

%

Against

%

01

35,042,909

99.900

Nil

0.00

34,924

0.100

02

34,840,996

99.330

Nil

0.00

234,879

0.670

03

28,794,146

82.091

Nil

0.00

6,281,729

17.909

04

28,807,698

82.126

Nil

0.00

6,269,884

17.874

05

34,854,006

99.363

Nil

0.00

223,576

0.637

06

34,828,949

99.291

Nil

0.00

248,633

0.709

07

34,854,513

99.364

Nil

0.00

223,069

0.636

08

34,854,513

99.364

Nil

0.00

223,069

0.636

09

35,026,916

99.860

Nil

0.00

48,959

0.140

10

35,029,648

99.869

Nil

0.00

45,976

0.131

11

35,024,511

99.854

Nil

0.00

51,364

0.146

12

35,014,864

99.826

Nil

0.00

61,011

0.174

13

35,014,269

99.824

Nil

0.00

61,606

0.176

-Ends-

Contacts

ECO Animal Health Group plc

David Hallas (Chief Executive Officer)

Christopher Wilks (Chief Financial Officer)


020 8447 8899

ICR Healthcare (Financial PR)

Mary-Jane Elliott

Jessica Hodgson

020 3709 5700

Singer Capital Markets (Nominated Adviser & Joint Broker)

Philip Davies

Sam Butcher

020 7496 3000

Panmure Liberum (Joint Broker)

Emma Earl

Will Goode

Mark Rogers

Rupert Dearden

020 3100 2000 

Equity Development

Hannah Crowe

Matt Evans

020 7065 2692

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

 Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

 Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com